Benitec Biopharma Inc. (BNTC) Financials

$11.49

south_east
-$0.61 (-5.04%)
Day's range
$11.44
Day's range
$12.5

BNTC Income statement / Annual

Last year (2024), Benitec Biopharma Inc.'s total revenue was $216,000.00, an increase of 188.00% from the previous year. In 2024, Benitec Biopharma Inc.'s net income was -$21.75 M. See Benitec Biopharma Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016 06/30/2015
Operating Revenue $216,000.00 $75,000.00 $73,000.00 $59,000.00 $97,000.00 $11.32 M $455,446.00 $450,311.00 $346,506.00 $829,127.00
Cost of Revenue $108,000.00 $381,000.00 $9,000.00 $123,000.00 $268,065.00 $426,506.00 $331,300.00 $209,018.00 $103,802.00 $30,680.00
Gross Profit $108,000.00 -$306,000.00 $64,000.00 -$64,000.00 -$171,065.00 $10.89 M $124,146.00 $241,293.00 $242,704.00 $798,447.00
Gross Profit Ratio 0.5 -4.08 0.88 -1.09 -1.76 0.96 0.27 0.54 0.7 0.96
Research and Development Expenses $15.61 M $12.77 M $11.27 M $7.02 M $3.00 M $2.17 M $5.06 M $5.32 M $9.92 M $4.78 M
General & Administrative Expenses $6.71 M $6.38 M $6.65 M $6.51 M $5.57 M $6.66 M $6.41 M $6.99 M $8.96 M $6.17 M
Selling & Marketing Expenses $277,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $6.99 M $6.38 M $6.65 M $6.51 M $5.57 M $6.66 M $6.41 M $6.99 M $8.96 M $6.17 M
Other Expenses -$216,000.00 -$30,000.00 -$79,000.00 $37,000.00 -$5,000.00 $154,774.00 $734.59 -$7.91 M -$2.68 M -$2.14 M
Operating Expenses $22.38 M $19.16 M $17.92 M $13.53 M $8.56 M $8.99 M $8.68 M $4.40 M $16.20 M $8.80 M
Cost And Expenses $22.49 M $19.16 M $17.93 M $13.66 M $8.38 M $9.41 M $9.01 M $4.61 M $16.31 M $8.84 M
Interest Income $0.00 $49,546.00 $46,348.00 $0.00 $62,000.00 $119,057.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $904,000.00 $33,000.00 $32,000.00 $6,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $0.00 $381,000.00 $392,000.00 $424,000.00 $374,000.00 $154,774.00 $142,510.00 $166,753.00 $11.54 M $74,399.00
EBITDA -$22.49 M -$18.70 M -$17.85 M -$13.60 M -$7.91 M $2.74 M -$8.59 M -$4.19 M -$13.42 M -$7.93 M
EBITDA Ratio -104.12 -249.73 -245.66 -225.07 -80.6 0.19 -18.47 -8.41 -38.72 -8.58
Operating Income Ratio -104.12 -254.41 -244.58 -230.44 -85.37 0.18 -18.78 -35.36 -72.04 -16.08
Total Other Income/Expenses Net $120,000.00 -$481,000.00 -$354,000.00 -$286,000.00 $7,000.00 $606,031.00 $179,240.00 $11.55 M $6.46 M $4.50 M
Income Before Tax -$22.37 M -$19.56 M -$18.21 M -$13.88 M -$8.27 M $2.87 M -$8.55 M -$4.37 M -$18.50 M -$8.83 M
Income Before Tax Ratio -103.56 -260.83 -249.42 -235.29 -85.3 0.25 -18.77 -9.71 -53.4 -10.65
Income Tax Expense -$619,000.00 $3,000.00 $354,000.00 -$101,000.00 $27,000.00 -$864,218.28 $1,469.18 $209,786.00 -$9.00 M $821,457.00
Net Income -$21.75 M -$19.56 M -$18.56 M -$13.78 M -$8.30 M $2.87 M -$8.55 M -$4.37 M -$18.50 M -$8.83 M
Net Income Ratio -100.7 -260.83 -254.27 -233.58 -85.58 0.25 -18.77 -9.71 -53.4 -10.65
EPS -2.68 -7.06 -19.31 -27.27 -69.095 28.445 -103.605 -63.555 -331.56 -194.885
EPS Diluted -2.68 -7.06 -19.31 -27.27 -69.095 28.445 -103.605 -63.555 -331.56 -194.885
Weighted Average Shares Out $16.24 M $5.54 M $1.92 M $1.01 M $240,280.00 $201,592.00 $165,060.00 $137,592.00 $111,616.00 $90,592.00
Weighted Average Shares Out Diluted $4.06 M $5.54 M $1.92 M $1.01 M $240,280.00 $201,592.00 $165,064.00 $137,596.00 $111,616.00 $90,592.00
Link